Fundamental Analysis
Jim Cramer: Why Simon Property's Taubman Centers Buy Is So Important
This is a statement buy that is changing the shopping mall narrative, and we need to see one in oil and gas next.
The Market Is Still Complacent on Coronavirus News
The market's resilience in the face of such an ugly threat has many market players trying to find ways to reconcile the movement with the news flow.
This High-Yield Oil Stock Is a Buy
Refiner has now met or exceeded analysts' EPS estimates for 15 quarters in a row, a very impressive streak given the cyclical nature of the oil industry.
The Wisdom of Taking Profits in Small Biotech Stocks Upon FDA Drug Approval
There are multiple reasons why these stocks often decline after their drugs receive the blessing of regulators.
Healthy Upside Potential In Medical Devices and Services Stocks
Some of the best opportunities are in lesser-known niche markets such as medical devices and services.
2 Healthcare Stocks That Look Like Bargains Relative to Their Growth Prospects
Alexion Pharmaceuticals and Lantheus Holdings are interesting names at current trading levels.
6 Favorite Financials: Value Stocks to Take to the Bank
These undervalued names fit well in a diversified portfolio.
2 Small Biotechs Face Crossroads Years in 2020
Dynavax Technologies and Omeros Corp. have tested shareholders' patience over time and again are at inflection points.
These Media Stocks Are Primed to Score Ahead of Super Bowl LIV
Recent viewership strength will likely support continued premium pricing on NFL programming, while streaming viewership of the 'Big Game' has exploded in recent years.
3 Reasons Why Apple Will Continue to Shine
This trio of reasons plus a chart that remains in a bull channel all point to a stock that should continue to outperform the markets in 2020.